Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
10/1999
10/20/1999CN1232388A Antimalarial and anti-babesiosis agent and pharmaceutical compositions contg. same
10/20/1999CN1232025A Pyrrolidine and piperidine derivatives
10/19/1999US5969158 Administering derivatives of homoserine lactone to inhibit histamine release from mast cells and/or basophils
10/19/1999US5969136 Sulfurization of a piperidine derivative, cyclization with guanidine, optionally salifying
10/19/1999US5968956 Substituted piperidine derivative and medicine comprising the same
10/19/1999US5968953 For side effect reduction
10/19/1999US5968942 Inhibitors of hiv protease
10/19/1999US5968938 Treating preterm labor in mammals, treating dysmenorrhea, stopping labor prior to cesarean delivery
10/19/1999US5968923 (Azetidin-1-ylalkyl) lactams as tachykinin antagonists
10/16/1999CA2269049A1 N-acyl and n-aroyl aralkyl amides
10/14/1999WO1999051578A1 Biocidal benzylbiphenyl derivatives
10/14/1999WO1999051571A1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
10/14/1999WO1999051565A1 Novel local anesthetic compounds and uses
10/14/1999WO1999051564A1 Propanolamine derivatives
10/14/1999WO1999045011A8 Glycine transport inhibitors
10/14/1999CA2326759A1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
10/14/1999CA2326159A1 Biocidal benzylbiphenyl derivatives
10/14/1999CA2315946A1 Novel local anesthetic compounds and uses
10/13/1999EP0949247A1 Process for the preparation of piperidinylidene derivatives
10/13/1999EP0948484A1 The preparation of enantiomerically-enriched threo-methylphenidate
10/13/1999EP0936912A4 Inhibitors of cysteine protease
10/13/1999EP0783486B1 Novel prostaglandin synthase inhibitors
10/13/1999CN1231665A Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
10/13/1999CN1231662A Quinazoline derivatives and pharmaceutical compositions containing them
10/13/1999CN1231659A Stable non-hygroscopic crystalline form of N-[N-N-(4-(piperidin-4-YL) butanoyl)-N-ethylglycyl] compound
10/13/1999CN1231286A 1,2-Di-substituted piperidine derivative, hair growth promoter and external composition for skin using the same
10/13/1999CN1045595C Process for the preparation of the intermediates used in the synthesis of 3-aminopiperidine derivatives
10/12/1999US5965734 Reacting 2-substituted pyridine with hydrogen in the presence of catalyst and alkanoic acid, adding aklyl alkanoate, and then reacting with aqueous base then with acid and resolving agent to form acid salts of 1-erythro piperidine stereosiomers
10/12/1999US5965580 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
10/12/1999US5965577 Heterocyclic inhibitors of microsomal triglyceride transfer protein and method
10/12/1999US5965562 Treating disorders induced by substance p and migraine headache
10/12/1999US5965496 Perfluoropolyether polymers and compounds having free radical, nitrogen-containing end groups to provide improved adhesion and durability to the surface of the magnetic recording medium
10/12/1999US5965054 Comprising salts consisting of alkyl substituted, nitrogen-containing heterocyclic delocalized aromatic cations, and their perfluoro derivatives; high energy, high voltage
10/12/1999CA1340785C Platelet activating factor antagonists
10/07/1999WO1999050247A1 Compounds with activity on muscarinic receptors
10/07/1999WO1999050237A1 Sulfonamide derivatives and drugs containing the same as the active ingredient
10/07/1999WO1999049856A2 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
10/07/1999CA2325997A1 Sulfonamide derivatives and drugs containing the same as the active ingredient
10/07/1999CA2325986A1 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
10/06/1999EP0947496A1 Bicyclic aromatic compounds and their use in human and veterinary medicine as well as in cosmetology
10/06/1999EP0946546A1 Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine
10/06/1999EP0946539A1 Sulphonamide derivatives, process for their preparation, and their use as medicaments
10/06/1999EP0946511A1 Novel compounds with analgesic effect
10/06/1999EP0946510A1 Novel compounds with analgesic effect
10/06/1999EP0946166A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing
10/06/1999CN1230962A 3-substituted pyrido [4',3' : 4, 5] thieno [2,3-D] pyrimidine derivatives, their preparation and their use
10/05/1999US5962695 Aromatic amidine derivatives and salts thereof
10/05/1999US5962690 Benzoic acid compounds
10/05/1999US5962689 Biosynthesis of antiserotonin agent
10/05/1999US5962531 5-aroylnaphthalene derivatives as anti-inflammatory agents
10/05/1999US5962472 Alzheimer's, parkinson, huntington diseases; amyotropic laterial sclerosis; nervous system disorders
10/05/1999US5962390 Cleaning process and composition
09/1999
09/30/1999WO1999048870A1 Piperididinyl and n-amidinopiperidinyl derivatives
09/30/1999WO1999048491A1 NF-λB INHIBITORS CONTAINING AS THE ACTIVE INGREDIENT PHENYLMETHYL BENZOQUINONE
09/30/1999WO1999048461A2 Substituted aromatic compounds for treatment of antibiotic resistant infections
09/30/1999WO1999006340A3 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
09/30/1999CA2325689A1 Substituted aromatic compounds for treatment of antibiotic resistant infections
09/30/1999CA2290630A1 Nf-kb inhibitors containing as the active ingredient phenylmethyl benzoquinone
09/30/1999CA2236127A1 Process for the preparation of piperidinylidene derivative
09/29/1999EP0945431A2 Process and intermediates for the preparation of phenylacetic derivatives
09/29/1999EP0944598A2 Substituted benzamide derivatives and pharmaceutical compositions containing them
09/29/1999EP0944590A2 Aminoguanidines and alkoxyguanidines as protease inhibitors
09/29/1999EP0944582A1 Ketobenzamides as calpain inhibitors
09/29/1999EP0944388A2 Inhibitors of farnesyl-protein transferase
09/29/1999CN1230196A Modified aminoacids, pharmaceuticals containing these compounds and method for their prodn.
09/29/1999CN1230179A Prepn. of 1-butyl-4-piperidinylmethylamine
09/29/1999CN1230175A Cytostatic hydroxamic acid derivatives
09/29/1999CN1230110A Cell adhesion inhibitors
09/28/1999US5959112 Solvent extraction to liberate hydrochloric acid salt with dilute base, pipecoloxylidide is resolved by crystallization with water, alkylating with 1-halopropane in presence of catalyst, heating and removing inorganic salt by extraction
09/28/1999US5958952 Substituted phenylamindines, medicaments containing these compounds and process for producing them
09/28/1999US5958949 N-linked ureas and carbamates of piperidyl thioesters
09/28/1999US5958918 Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N- (aminominomethyl)phenylalkyl!-azaheterocyclylamide compounds
09/28/1999US5958792 Combinatorial libraries of substrate-bound cyclic organic compounds
09/28/1999CA2014457C Pyrimidine derivatives
09/23/1999WO1999047693A1 Novel method for preparing fexofenadine
09/23/1999WO1999047508A1 Benzenesulfonamide-derivatives and their use as medicaments
09/23/1999WO1999047491A1 Fluorovinyloxyacetamides, process for preparing same and herbicidal composition comprising same
09/23/1999CA2323783A1 Benzenesulfonamide-derivatives and their use as medicaments
09/22/1999EP0943615A1 1,4-dihydropyridine derivatives
09/22/1999EP0942901A1 Cyclic imines as pesticides
09/22/1999EP0942735A1 Use of nk-1 receptor antagonists for treating schizophrenic disorders
09/22/1999EP0942734A1 Use of nk-1 receptor antagonists for treating severe anxiety disorders
09/22/1999EP0942733A1 Use of nk-1 receptor antagonists for treating cognitive disorders
09/22/1999EP0942732A1 Use of nk-1 receptor antagonists for treating movement disorders
09/22/1999EP0942731A1 Use of nk-1 receptor antagonists for treating substance use disorders
09/22/1999EP0942730A1 Use of nk-1 receptor antagonists for treating bipolar disorders
09/22/1999EP0942729A1 Use of nk-1 receptor antagonists for treating stress disorders
09/22/1999EP0942728A1 Use of nk-1 receptor antagonists for treating sexual dysfunction
09/21/1999US5955606 Photoresists of polyvinyllactams
09/21/1999US5955548 Substituted 3, 3-diamino-2-propenenitriles, their preparation and use
09/21/1999US5955482 Use of 1,4-dihydropyridine-3,5-dicarboxylic acid esters as medicaments
09/21/1999US5955479 Levobupivacaine for managing chronic pain
09/21/1999US5955478 Methods for treating gastrointestinal motility dysfunction using optically pure (+) cisapride
09/21/1999US5955477 Methods for treating gastrointestinal motility dysfunction using optically pure (--) cisapride
09/16/1999WO1999046261A1 Nitroxyl derivatives with glycidyl or alkylcarbonyl groups as initiators for radical polymerisation
09/16/1999WO1999046254A2 Amino anthracyclinone derivatives and their use in the treatment of amyloidosis
09/16/1999WO1999046245A2 PROCESSES FOR THE PREPARATION OF (R)-α- (2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL
09/16/1999WO1999045925A1 Novel opiate compounds, methods of making and methods of use
09/16/1999WO1999045913A1 Combination therapy and composition for acute coronary ischemic syndrome and related conditions
09/16/1999WO1999029321A9 Inhibition of membrane-associated viral replication